CLINICAL IMPORTANCE OF HEPATIC CYTOCHROME-P450 IN DRUG-METABOLISM

被引：224
作者：
SPATZENEGGER, M [1 ]
JAEGER, W [1 ]
机构：
[1] UNIV VIENNA,INST PHARMACEUT CHEM,A-1090 VIENNA,AUSTRIA
来源：
DRUG METABOLISM REVIEWS | 1995年 / 27卷 / 03期
关键词：
D O I：
10.3109/03602539508998329
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：397 / 417
页数：21
相关论文
共 143 条
[1]   THE PHARMACOKINETICS OF ONDANSETRON AFTER INTRAVENOUS-INJECTION IN HEALTHY-VOLUNTEERS PHENOTYPED AS POOR OR EXTENSIVE METABOLIZERS OF DEBRISOQUINE [J].
ASHFORTH, EIL ;
PALMER, JL ;
BYE, A ;
BEDDING, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (04) :389-391
[2]   INVIVO EVIDENCE THAT ETHOSUXIMIDE IS A SUBSTRATE FOR CYTOCHROME-P450IIIA [J].
BACHMANN, K ;
CHU, CA ;
GREEAR, V .
PHARMACOLOGY, 1992, 45 (03) :121-128
[3]   INDUCTION OF CYTOCHROME-P450 AND PEROXISOMAL ENZYMES BY CLOFIBRIC ACID INVIVO AND INVITRO [J].
BARS, RG ;
BELL, DR ;
ELCOMBE, CR .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2045-2053
[4]   EFFECT OF CYTOCHROME-P-450 1A INDUCTION ON ENANTIOSELECTIVE METABOLISM AND PHARMACOKINETICS OF AN ARYLTRIFLUOROMETHYL SULFIDE IN THE RAT [J].
BENOIT, E ;
BURONFOSSE, T ;
DELATOUR, P .
CHIRALITY, 1994, 6 (05) :372-377
[5]  
BERSON A, 1993, J PHARMACOL EXP THER, V265, P366
[6]  
BOELSTERLI UA, 1992, DRUG METAB DISPOS, V20, P96
[7]  
BOLAJI OO, 1993, RES COMMUN CHEM PATH, V82, P111
[8]  
BORNHEIM LM, 1992, DRUG METAB DISPOS, V20, P241
[9]  
BOTSCH S, 1993, MOL PHARMACOL, V43, P120
[10]  
BOURDI M, 1992, MOL PHARMACOL, V42, P280
12345678910